Results 101 to 110 of about 9,484 (203)

Efficacy and tolerability of a large scale change in regimen from latanoprost to travoprost in glaucoma patients at the Manhattan Veterans Administration Hospital

Clinical Ophthalmology, 2008
Edmund P FarrisNew York University, New York, NY; Manhattan Veterans Administration Hospital, New York, NY; New York Medical College, Valhalla, NY, USAObjective: This retrospective study was designed to investigate the efficacy and tolerability of ...
Edmund P Farris
doaj  

Effect of treatment with carteolol and latanoprost in newly diagnosed primary open-angle glaucoma on peripapillary vessel density

Biomedical Papers
Background and Aim. In a previous follow-up of glaucoma patients taking carteolol or latanoprost, we found a greater progression of visual field changes with the prostaglandin than the betablocker. In the present study we compared the impact of carteolol
Lestak Jan, Fus Martin, Pitrova Sarka
doaj   +1 more source

Bilateral keratoprostheses in a patient with ocular mucous membrane pemphigoid. [PDF]

, 2019
Mucous membrane pemphigoid (MMP) with ocular involvement, also referred to as ocular cicatricial pemphigoid, is a rare, autoimmune blistering disease that can have devastating effects for patients.
Bromley, Jennifer, DeGrazia, Taryn, Feldman, Ron   +2 more
core  

Nuevos Tratamientos para el Glaucoma: Inhibidores de Rho-quinasa [PDF]

, 2019
En la presente revisión bibliográfica hemos recogido información acerca de los inhibidores de Rho-quinasa como nuevos fármacos para el tratamiento del glaucoma primario de ángulo abierto.
Ruiz Sánchez, Cristina
core  

Evaluation of frequency doubling perimetry in ocular hypertone [PDF]

, 2000
Fossarello, M, Nessi, M, Serra, A., Zucca, I   +3 more
core   +1 more source

Better tolerance of preservative-free latanoprost compared to preserved glaucoma eye drops: the 12-month real-life FREE study

Clinical Ophthalmology, 2018
Mario A Economou,1 Helene Kolstad Laukeland,2,3 Iwona Grabska-Liberek,4 Jean-François Rouland5 1Anterior Segment Department, St Erik’s Eye Hospital, Karolinska Institute, Stockholm, Sweden; 2Department of Ophthalmology, University Hospital,
Economou MA, Laukeland HK, Grabska-Liberek I, Rouland JF   +3 more
doaj  

Twenty-four hour efficacy of glaucoma medications [PDF]

, 2015
Katsanos, Andreas, Konstas, Anastasios G. P., Mikropoulos, Dimitrios G., QUARANTA, Luciano, Teus, Miguel A., Tranos, Paris G.   +5 more
core   +1 more source

Benefits of switching from latanoprost to preservative-free tafluprost eye drops: a meta-analysis of two Phase IIIb clinical trials

Clinical Ophthalmology, 2016
Hannu Uusitalo,1 Evgeniy Egorov,2 Kai Kaarniranta,3 Yuri Astakhov,4 Auli Ropo5 On behalf of the Switch Study Tafluprost Study Groups 1Department of Ophthalmology, SILK, University of Tampere, Tampere University Hospital, Tampere, Finland; 2Department ...
Uusitalo H, Egorov E, Kaarniranta K, Astakhov Y, Ropo A   +4 more
doaj  

Efficacy and safety of switching to latanoprost 0.005%–timolol maleate 0.5% fixed-combination eyedrops from an unfixed combination for 36 months

Clinical Ophthalmology, 2014
Kenji Inoue,1 Ryoko Okayama,1 Risako Higa,1 Goji Tomita2 1Inouye Eye Hospital, Tokyo, 2Second Department of Ophthalmology, Toho University School of Medicine, Tokyo, Japan Purpose: We prospectively investigated the intraocular pressure (IOP)-reducing ...
Inoue K, Okayama R, Higa R, Tomita G
doaj  

Latanoprost ophthalmic solution in the treatment of open angle glaucoma or raised intraocular pressure: a review

Clinical Ophthalmology, 2009
Andrea Russo, Ivano Riva, Teodoro Pizzolante, Federico Noto, Luciano QuarantaCattedra di Malattie dell’Apparato Visivo, Università degli studi di Brescia, USVD “Centro per lo studio del Glaucoma” Spedali Civili di
Andrea Russo, Ivano Riva, Teodoro Pizzolante, Federico Noto, Luciano Quaranta   +4 more
doaj